• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019年冠状病毒病大流行期间心脏植入式电子设备患者的远程管理

Remote Management of Patients with Cardiac Implantable Electronic Devices during the COVID-19 Pandemic.

作者信息

Nagy Bettina, Pál-Jakab Ádám, Kiss Boldizsár, Orbán Gábor, Sélley Torda László, Dabasi-Halász Zsigmond, Móka Barbara Bernadett, Gellér László, Merkely Béla, Zima Endre

机构信息

Heart and Vascular Centre, Faculty of Medicine, Semmelweis University, 1122 Budapest, Hungary.

Biotronik Hungária Kft., 1124 Budapest, Hungary.

出版信息

J Cardiovasc Dev Dis. 2023 May 14;10(5):214. doi: 10.3390/jcdd10050214.

DOI:10.3390/jcdd10050214
PMID:37233181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10219157/
Abstract

Remote monitoring (RM) is the newest function of cardiac implantable electronic devices (CIEDs). In our observational retrospective analysis, we aimed to assess whether telecardiology could be a safe alternative to routine outpatient examinations during the COVID-19 pandemic. The in- and outpatient visits, the number of acute cardiac decompensation episodes, the RM data from CIEDs, and general condition were examined via questionnaires (KCCQ, EQ-5D-5L). Regarding the enrolled 85 patients, the number of personal patient appearances was significantly lower in the year following the pandemic outbreak compared to the previous year (1.4 ± 1.4 and 1.9 ± 1.2, = 0.0077). The number of acute decompensation events was five before and seven during lockdown ( = 0.6). Based on the RM data, there was no significant difference in heart failure (HF) markers (all related > 0.05); only patient activity increased after restrictions were lifted compared to that before the lockdown ( = 0.03). During restrictions, patients reported increased anxiety and depression compared to their previous state ( < 0.001). There was no subjective change in the perception of HF symptoms ( = 0.7). Based on the subjective perception and CIED data, the quality of life of patients with CIED did not deteriorate during the pandemic, but their anxiety and depression intensified. Telecardiology may be a safe alternative to routine inpatient examination.

摘要

远程监测(RM)是植入式心脏电子设备(CIEDs)的最新功能。在我们的观察性回顾分析中,我们旨在评估在2019年冠状病毒病(COVID-19)大流行期间,远程心脏病学是否可以作为常规门诊检查的安全替代方案。通过问卷调查(堪萨斯城心肌病问卷、EQ-5D-5L)对门诊和住院就诊情况、急性心脏失代偿发作次数、CIEDs的RM数据以及一般状况进行了检查。对于纳入的85例患者,大流行爆发后的一年中患者亲自就诊的次数与上一年相比显著减少(分别为1.4±1.4和1.9±1.2,P = 0.0077)。封锁前急性失代偿事件的数量为5次,封锁期间为7次(P = 0.6)。根据RM数据,心力衰竭(HF)标志物无显著差异(所有相关P>0.05);与封锁前相比,限制解除后患者活动量增加(P = 0.03)。在限制期间,与之前状态相比,患者报告焦虑和抑郁增加(P<0.001)。HF症状的主观感受无变化(P = 0.7)。基于主观感受和CIED数据,CIED患者的生活质量在大流行期间没有恶化,但焦虑和抑郁加剧。远程心脏病学可能是常规住院检查的安全替代方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85e4/10219157/94838b59e89e/jcdd-10-00214-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85e4/10219157/31047a249929/jcdd-10-00214-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85e4/10219157/94838b59e89e/jcdd-10-00214-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85e4/10219157/31047a249929/jcdd-10-00214-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85e4/10219157/94838b59e89e/jcdd-10-00214-g002.jpg

相似文献

1
Remote Management of Patients with Cardiac Implantable Electronic Devices during the COVID-19 Pandemic.2019年冠状病毒病大流行期间心脏植入式电子设备患者的远程管理
J Cardiovasc Dev Dis. 2023 May 14;10(5):214. doi: 10.3390/jcdd10050214.
2
Impact of COVID-19 Pandemic on Remote Monitoring of Cardiac Implantable Electronic Devices in Italy: Results of a Survey Promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing).COVID-19大流行对意大利心脏植入式电子设备远程监测的影响:意大利心律学与心脏起搏协会(AIAC)开展的一项调查结果
J Clin Med. 2021 Sep 10;10(18):4086. doi: 10.3390/jcm10184086.
3
Impact of the COVID-19 pandemic on implantation of cardiac implantable electronic devices and remote monitoring activations.COVID-19 大流行对心脏植入式电子设备植入和远程监测激活的影响。
Rev Esp Cardiol (Engl Ed). 2024 Mar;77(3):243-253. doi: 10.1016/j.rec.2023.07.003. Epub 2023 Jul 27.
4
Remote monitoring: Doomed to let down or an attractive promise?远程监测:注定令人失望还是诱人的前景?
Int J Cardiol Heart Vasc. 2019 May 30;24:100380. doi: 10.1016/j.ijcha.2019.100380. eCollection 2019 Sep.
5
The use of remote monitoring of cardiac implantable devices during the COVID-19 pandemic: an EHRA physician survey.在 COVID-19 大流行期间使用远程监测心脏植入式设备:EHRA 医生调查。
Europace. 2022 Mar 2;24(3):473-480. doi: 10.1093/europace/euab215.
6
Management of cardiac implantable electronic device follow-up in COVID-19 pandemic: Lessons learned during Italian lockdown.COVID-19 大流行期间心脏植入式电子设备随访的管理:意大利封锁期间的经验教训。
J Cardiovasc Electrophysiol. 2020 Nov;31(11):2814-2823. doi: 10.1111/jce.14755. Epub 2020 Sep 30.
7
Home Management of Heart Failure and Arrhythmias in Patients with Cardiac Devices during Pandemic.疫情期间心脏装置患者心力衰竭和心律失常的居家管理
J Clin Med. 2021 Apr 11;10(8):1618. doi: 10.3390/jcm10081618.
8
Cardiac implantable electronic devices replacements in patients followed by remote monitoring during COVID-19 lockdown.新冠疫情封锁期间接受远程监测的患者的心脏植入式电子设备更换情况。
Eur Heart J Digit Health. 2021 Jan 11;2(1):171-174. doi: 10.1093/ehjdh/ztaa018. eCollection 2021 Mar.
9
Protecting the most vulnerable during COVID-19 and beyond: a case report on the remote management of heart failure patients with cardiac implantable electronic devices.在新冠疫情期间及之后保护最脆弱人群:一例关于使用心脏植入式电子设备对心力衰竭患者进行远程管理的病例报告
Eur Heart J Case Rep. 2020 Sep 9;4(FI1):1-6. doi: 10.1093/ehjcr/ytaa249. eCollection 2020 Oct.
10
Remote monitoring of cardiac implantable devices during COVID-19 outbreak: "keep people safe" and "focus only on health care needs".在 COVID-19 大流行期间对心脏植入设备进行远程监测:“保障人民安全”和“只关注医疗保健需求”。
Acta Cardiol. 2021 Apr;76(2):158-161. doi: 10.1080/00015385.2020.1847459. Epub 2020 Nov 18.

引用本文的文献

1
Enhancing Heart Failure Management: A Systematic Review and Meta-Analysis of Continuous Remote Telemedical Management vs. In-Person Visit in Patients with Cardiac Implantable Electronic Devices.加强心力衰竭管理:对心脏植入式电子设备患者进行持续远程远程医疗管理与面对面就诊的系统评价和荟萃分析
J Clin Med. 2025 Jun 16;14(12):4278. doi: 10.3390/jcm14124278.
2
Predicting the Higher Energy Need for Effective Defibrillation Using Machine Learning Based on an Animal Model.基于动物模型利用机器学习预测有效除颤所需的更高能量需求。
J Clin Med. 2025 May 30;14(11):3879. doi: 10.3390/jcm14113879.
3
Holistic Approaches to Arrhythmia Management: Combining Medication, Ablation, and Device Interventions.

本文引用的文献

1
Device-detected atrial fibrillation in a large remote-monitored cohort: implications for anticoagulation and need for new pathways of service delivery.设备检测到的大型远程监测队列中的心房颤动:抗凝治疗的意义和新的服务提供途径的需求。
J Interv Card Electrophysiol. 2023 Oct;66(7):1659-1668. doi: 10.1007/s10840-023-01481-4. Epub 2023 Feb 3.
2
Inter-American Society of Cardiology (CIFACAH-ELECTROSIAC) and Latin-American Heart Rhythm Society (LAHRS): multidisciplinary review on the appropriate use of implantable cardiodefibrillator in heart failure with reduced ejection fraction.美洲心脏病学会(CIFACAH-ELECTROSIAC)和拉丁美洲心律学会(LAHRS):关于心力衰竭伴射血分数降低的植入式心脏除颤器的适当使用的多学科综述。
J Interv Card Electrophysiol. 2023 Aug;66(5):1211-1229. doi: 10.1007/s10840-022-01425-4. Epub 2022 Dec 5.
3
心律失常管理的整体方法:药物、消融和器械干预相结合
Cureus. 2023 Sep 25;15(9):e45958. doi: 10.7759/cureus.45958. eCollection 2023 Sep.
Clinical utility of remote monitoring for patients with cardiac implantable electrical devices.远程监测在心脏植入式电子设备患者中的临床应用。
J Interv Card Electrophysiol. 2023 Jun;66(4):961-969. doi: 10.1007/s10840-022-01406-7. Epub 2022 Nov 3.
4
Impact of coronavirus disease 19 outbreak on arrhythmic events and mortality among implantable cardioverter defibrillator patients followed up by remote monitoring: a single center study from the Veneto region of Italy.新型冠状病毒病 19 爆发对接受远程监测的植入式心律转复除颤器患者心律失常事件和死亡率的影响:来自意大利威尼托地区的单中心研究。
J Cardiovasc Med (Hagerstown). 2022 Aug 1;23(8):546-550. doi: 10.2459/JCM.0000000000001348.
5
Impact of synchronized left ventricular pacing rate on risk for ventricular tachyarrhythmias after cardiac resynchronization therapy in patients with heart failure.心脏再同步化治疗后左心室起搏频率同步性对心力衰竭患者室性心律失常风险的影响。
J Interv Card Electrophysiol. 2022 Oct;65(1):239-249. doi: 10.1007/s10840-022-01284-z. Epub 2022 Jun 23.
6
Stress and cardiovascular risk burden after the pandemic: current status and future prospects.疫情后压力与心血管风险负担:现状与未来展望。
Expert Rev Cardiovasc Ther. 2022 Jul;20(7):507-513. doi: 10.1080/14779072.2022.2092097. Epub 2022 Jun 23.
7
Heart rate variability and cardiac autonomic functions in post-COVID period.新冠康复期的心率变异性和心脏自主神经功能
J Interv Card Electrophysiol. 2022 Apr;63(3):715-721. doi: 10.1007/s10840-022-01138-8. Epub 2022 Feb 1.
8
Implantable Cardioverter Defibrillator Multisensor Monitoring during Home Confinement Caused by the COVID-19 Pandemic.2019年冠状病毒病疫情居家隔离期间植入式心脏复律除颤器多传感器监测
Biology (Basel). 2022 Jan 12;11(1):120. doi: 10.3390/biology11010120.
9
Association of device-measured physical activity with peak oxygen consumption measured by cardiopulmonary exercise testing in patients with cardiac implantable electronic devices.心脏植入式电子设备患者的设备测量体力活动与心肺运动试验测量的峰值耗氧量之间的关联。
J Interv Card Electrophysiol. 2022 Apr;63(3):651-659. doi: 10.1007/s10840-021-01095-8. Epub 2021 Nov 26.
10
Letter to the editor to update the article "Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials".给编辑的信,以更新文章“使用植入式设备对心力衰竭进行远程监测:随机对照试验的系统评价、荟萃分析和荟萃回归”。
Heart Fail Rev. 2022 May;27(3):985-987. doi: 10.1007/s10741-021-10190-x. Epub 2021 Nov 9.